Multiregional profiling reveals <i>THBS1</i>-<i>SPP1</i> monocyte-macrophage axis drives immunosuppression and outcome in colorectal liver metastases.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 42172319.
- Also identified by DOI 10.1126/sciadv.aed1296 and PMC identifier 13196778.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Colorectal cancer (CRC) commonly metastasizes to the liver (CRLM), where it is the leading cause of CRC-related deaths. While immune checkpoint therapies show promise, their effectiveness is limited in CRLM due to the immunosuppressive liver tumor microenvironment (TME). Using multiregional tissue sampling from CRLM patient samples, we identified distinct immune zones within CRLM. Active Granzyme<sup>+</sup>CD8<sup>+</sup> T cells were found in normal liver tissue, while CD8<sup>+</sup> T cells in the tumor core were dysfunctional. At the tumor margin, we observed a pre-exhausted immune zone enriched in <i>THBS1<sup>+</sup></i> monocytes and CD47<i><sup>+</sup></i>CD8<i><sup>+</sup></i> T cells. Trajectory analysis showed that <i>THBS1<sup>+</sup></i> monocytes differentiate into <i>SPP1<sup>+</sup></i> macrophages, which accumulate in the tumor core and promote immune suppression via <i>TIM-3</i> and <i>CTLA-4</i> on exhausted CD8<sup>+</sup> T cells. The presence of <i>SPP1<sup>+</sup></i> macrophages correlates with increased T cell exhaustion and poor survival, suggesting them as potential targets to restore antitumor immunity in CRLM.
Medical subject headings
- Colorectal Neoplasms
- Liver Neoplasms
- Macrophages
- Thrombospondin 1
- Monocytes